NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
David Fruman
University of California Irvine - Irvine / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1749019
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
David Fruman's MOST POPULAR ARTICLES
1-)
The PI3K pathway in human diseaseDA Fruman, H Chiu, BD Hopkins, S Bagrodia, LC Cantley, RT AbrahamCell 170 (4), 605-635, 201721432017
2-)
Phosphoinositide 3-kinasesDA FrumanHandbook of Cell Signaling (Second Edition), 1049-1060, 20092133*2009
3-)
Phosphoinositide kinasesDA Fruman, RE Meyers, LC CantleyAnnual review of biochemistry 67 (1), 481-507, 199820471998
4-)
Phosphoinositide kinasesDA Fruman, RE Meyers, LC CantleyAnnual review of biochemistry 67 (1), 481-507, 199821361998
5-)
PI3K and cancer: lessons, challenges and opportunitiesDA Fruman, C RommelNature reviews Drug discovery 13 (2), 140-156, 201418582014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept